Product List
Edoxaban intermediate C | 1243308-37-3
Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It was developed by Daiichi Sankyo and approved in July 2011 in Japan ……
Edoxaban | 912273-65-5
"
Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It was developed by Daiichi Sankyo and approved in July 2011 in Jap……
Edoxaban intermediate A1 | 1353893-22-7
"
Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It was developed by Daiichi Sankyo and approved in July 2011 in Japa……
Edoxaban intermediate A2 | 1210348-34-7
"
Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It was developed by Daiichi Sankyo and approved in July 2011 in Japa……
Edoxaban intermediate As | 365998-36-3
"
Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor. It was developed by Daiichi Sankyo and approved in July 2011 in Japa……
Ixazomib | 1072833-77-2
"
Ixazomib (also known as MLN9708) is a type of cancer drug called a proteasome inhibitor.
Ixazomib is in the same class of drugs as bortezomib and ……
Ibrutinib | 936563-96-1
"
Ibrutinib is an anticancer drug targeting B-cell malignancies. It was approved by the US FDA on November 13, 2013 for the treatment of mantle cell……
1-Bromo-2-butyne,3355-28-0 | 3355-28-0
Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes.
Linagliptin (once-daily) was approved by the U……
N,N-Bis-(Hydroxyethyl)-4-Fluoro-3-Nitroaniline | 29705-38-2
"
Bendamustine is a nitrogen mustard used in the treatment of chronic lymphocytic leukemia and lymphomas. It belongs to the family of drugs called a……